US5609884A
(en)
*
|
1992-08-31 |
1997-03-11 |
G. D. Searle & Co. |
Controlled release naproxen sodium plus naproxen combination tablet
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
JPH07223970A
(ja)
*
|
1994-02-10 |
1995-08-22 |
Tanabe Seiyaku Co Ltd |
消化管内適所放出製剤
|
US6887461B1
(en)
*
|
1998-10-26 |
2005-05-03 |
Genetics Institute, Llc |
Method of using IL-11 for treating mucositis
|
US6548084B2
(en)
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
JPH0940561A
(ja)
*
|
1995-08-02 |
1997-02-10 |
Fujitsukusu Kk |
瀉下剤
|
US6486177B2
(en)
*
|
1995-12-04 |
2002-11-26 |
Celgene Corporation |
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
|
US5922736A
(en)
*
|
1995-12-04 |
1999-07-13 |
Celegene Corporation |
Chronic, bolus administration of D-threo methylphenidate
|
US5837284A
(en)
*
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
US8022095B2
(en)
*
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
GB9706089D0
(en)
*
|
1997-03-24 |
1997-05-14 |
Scherer Ltd R P |
Pharmaceutical composition
|
US6962997B1
(en)
*
|
1997-05-22 |
2005-11-08 |
Celgene Corporation |
Process and intermediates for resolving piperidyl acetamide steroisomers
|
IN186245B
(de)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US6607751B1
(en)
*
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
AU2004222771B2
(en)
*
|
1998-07-30 |
2006-09-21 |
Pfizer Inc. |
Prevention of Migraine Recurrence
|
GB9816556D0
(en)
*
|
1998-07-30 |
1998-09-30 |
Pfizer Ltd |
Therapy
|
US6602521B1
(en)
*
|
1998-09-29 |
2003-08-05 |
Impax Pharmaceuticals, Inc. |
Multiplex drug delivery system suitable for oral administration
|
US20080118556A1
(en)
*
|
1998-11-02 |
2008-05-22 |
Elan Corporation, Plc |
Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone
|
US20090149479A1
(en)
*
|
1998-11-02 |
2009-06-11 |
Elan Pharma International Limited |
Dosing regimen
|
US20060240105A1
(en)
*
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
DK1126826T6
(en)
*
|
1998-11-02 |
2019-06-24 |
Alkermes Pharma Ireland Ltd |
Multiparticulate modified release of methylphenidate
|
PE20001302A1
(es)
|
1998-11-27 |
2000-11-30 |
Hoffmann La Roche |
Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
|
US6270807B1
(en)
|
1999-03-02 |
2001-08-07 |
L. Perrigo Company |
Taste-masked pharmaceutical composition
|
US6632451B2
(en)
*
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
EP1064938A1
(de)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Pharmazeutische Dosierungsformen zur kontrollierte Wirkstoffabgabe mit mindenstens ein pulsierendem Zeitverlauf
|
US20040258750A1
(en)
*
|
1999-06-28 |
2004-12-23 |
Gerard Alaux |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
US20020028240A1
(en)
*
|
2000-04-17 |
2002-03-07 |
Toyohiro Sawada |
Timed-release compression-coated solid composition for oral administration
|
US6620431B1
(en)
|
2000-04-17 |
2003-09-16 |
Charles Signorino |
Shellac film coatings providing release at selected pH and method
|
IT1318571B1
(it)
*
|
2000-06-09 |
2003-08-27 |
Farmaka Srl |
Composizioni cosmetiche per la cura del cuoio capelluto e dei capelli.
|
US6500457B1
(en)
|
2000-08-14 |
2002-12-31 |
Peirce Management, Llc |
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
|
WO2002066002A2
(en)
*
|
2001-02-14 |
2002-08-29 |
Glaxo Wellcome S.A. |
Pharmaceutical formulation
|
US20030072731A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing starch or dextrin
|
AU4061702A
(en)
*
|
2001-05-15 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Dip coating compositions containing starch or dextrin
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US8309118B2
(en)
*
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
CA2409552A1
(en)
*
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20040052843A1
(en)
*
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
EP1465606A4
(de)
*
|
2001-12-24 |
2009-04-22 |
Teva Pharma |
Dosierungsform mit einem von einem verpressten ringförmigen körper aus pulver- oder granulatmaterial umhüllten tablettenkern aus aktivem bestandteil sowie verfahren und gerät zur herstellung davon
|
CA2480403A1
(en)
*
|
2002-04-08 |
2003-10-23 |
Lavipharm Laboratories Inc. |
Drug-complex microparticles and methods of making/using same
|
CN1681493A
(zh)
*
|
2002-07-19 |
2005-10-12 |
兰贝克赛实验室有限公司 |
掩味舒马曲坦片剂及其制备方法
|
US7429619B2
(en)
*
|
2002-08-02 |
2008-09-30 |
Mcneil Consumer Healthcare |
Polyacrylic film forming compositions
|
US20040068000A1
(en)
*
|
2002-10-02 |
2004-04-08 |
Mintong Guo |
Compression coated tablets
|
US20080220074A1
(en)
*
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
MY148805A
(en)
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
AU2003303631B2
(en)
*
|
2002-12-26 |
2008-05-29 |
Nuvo Pharmaceuticals (Ireland) Designated Activity Company |
Multilayer Dosage Forms Containing NSAIDs and Triptans
|
CA2519211A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Takeda Pharmaceutical Company Limited |
Release control compositions
|
US20040241252A1
(en)
*
|
2003-05-29 |
2004-12-02 |
Abney Christopher Charles |
Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
|
CA2527368A1
(en)
*
|
2003-06-06 |
2004-12-23 |
Glaxo Group Limited |
Pharmaceutical composition
|
US7390503B1
(en)
*
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US20070122480A1
(en)
*
|
2003-09-29 |
2007-05-31 |
Cj Corporation |
Sustained release formulations
|
GB0400452D0
(en)
*
|
2004-01-09 |
2004-02-11 |
Norton Healthcare Ltd |
A pharmaceutical composition
|
GB0403628D0
(en)
*
|
2004-02-18 |
2004-03-24 |
Arrow Group Ltd |
Compression-coated tablets and the manufacture thereof
|
US20050239830A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Vikram Khetani |
Methods of diminishing co-abuse potential
|
EP1750677B1
(de)
*
|
2004-05-28 |
2017-02-01 |
Imaginot Pty Ltd. |
Abgabesystem für eine orale therapeutische verbindung
|
US8216610B2
(en)
*
|
2004-05-28 |
2012-07-10 |
Imaginot Pty Ltd. |
Oral paracetamol formulations
|
US20060024361A1
(en)
*
|
2004-07-28 |
2006-02-02 |
Isa Odidi |
Disintegrant assisted controlled release technology
|
AU2005266459A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Sanofi-Aventis |
Pharmaceutical multilayer tablet for controlled release of active ingredients with highly pH-dependent solubility
|
US20060024368A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Reza Fassihi |
Compressed composite delivery system for release-rate modulation of bioactives
|
US10624858B2
(en)
*
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
WO2006035313A1
(en)
*
|
2004-09-29 |
2006-04-06 |
Aurobindo Pharma Ltd |
Solid unit dosage forms of 5-ht1 agonist
|
US20060240043A1
(en)
*
|
2004-10-08 |
2006-10-26 |
Meyerson Laurence R |
Methods and compositions for treating migraine pain
|
US20060121112A1
(en)
*
|
2004-12-08 |
2006-06-08 |
Elan Corporation, Plc |
Topiramate pharmaceutical composition
|
US20060127421A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Celgene Corporation |
Treatment using D-threo methylphenidate
|
WO2006110807A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
|
US20100136106A1
(en)
*
|
2005-06-08 |
2010-06-03 |
Gary Liversidge |
Modified Release Famciclovir Compositions
|
EP1954298A4
(de)
*
|
2005-11-28 |
2012-10-31 |
Imaginot Pty Ltd |
Abgabesystem für eine orale therapeutische verbindung
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US9265732B2
(en)
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
BRPI0708640A8
(pt)
*
|
2006-03-06 |
2018-04-24 |
Pozen Inc |
composição farmacêutica, e, métodos para tratar um paciente com dor de cabeça de enxaqueca, para tratar um paciente com dor e para tratar um paciente com enxaqueca
|
US9561188B2
(en)
|
2006-04-03 |
2017-02-07 |
Intellipharmaceutics Corporation |
Controlled release delivery device comprising an organosol coat
|
WO2007112579A1
(en)
*
|
2006-04-03 |
2007-10-11 |
Isa Odidi |
Drug delivery composition
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
SG174026A1
(en)
|
2006-08-03 |
2011-09-29 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid disease
|
PL2124556T3
(pl)
|
2006-10-09 |
2015-02-27 |
Charleston Laboratories Inc |
Kompozycje farmaceutyczne
|
KR100885029B1
(ko)
*
|
2007-02-07 |
2009-02-23 |
지엘팜텍 주식회사 |
경구투여용 서방성 삼중정제
|
EP1970056A1
(de)
*
|
2007-03-15 |
2008-09-17 |
Polichem S.A. |
Zeitspezifische Dosierformen mit verzögerter/pulsatiler Freisetzung
|
US9138430B2
(en)
*
|
2007-12-27 |
2015-09-22 |
Mylan Specialty L.P. |
Formulation and method for the release of paroxetine in the large intestine
|
EP2240022B1
(de)
|
2008-01-09 |
2016-12-28 |
Charleston Laboratories, Inc. |
Oxycodone und Promethazine enthaltende zweischichtige Tabletten
|
EP2829265B1
(de)
*
|
2008-04-28 |
2016-08-24 |
Zogenix, Inc. |
Neuartige Formulierungen zur Behandlung von Migräne
|
CA2749646A1
(en)
*
|
2009-01-26 |
2010-07-29 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of asthma
|
NZ582836A
(en)
*
|
2009-01-30 |
2011-06-30 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
|
EP2403487A2
(de)
*
|
2009-03-04 |
2012-01-11 |
Fdc Limited |
Orale darreichungsformen mit verzögerter freisetzung für wasserlösliche arzneimittel
|
WO2011006012A1
(en)
|
2009-07-08 |
2011-01-13 |
Charleston Laboratories Inc. |
Pharmaceutical compositions
|
GB201003731D0
(en)
*
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Immediate/delayed drug delivery
|
GB201003766D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Pulsatile drug release
|
GB201003734D0
(en)
|
2010-03-05 |
2010-04-21 |
Univ Strathclyde |
Delayed prolonged drug delivery
|
CN103370058A
(zh)
|
2010-12-22 |
2013-10-23 |
普渡制药公司 |
包覆的抗篡改控制释放剂型
|
CN107412173A
(zh)
|
2010-12-23 |
2017-12-01 |
普渡制药公司 |
抗篡改固体口服剂型
|
MX2015010041A
(es)
|
2013-02-05 |
2015-10-30 |
Purdue Pharma Lp |
Formulacion farmaceuticas resistentes a la alteracion.
|
US9890119B2
(en)
|
2013-02-27 |
2018-02-13 |
Shionogi & Co., Ltd. |
Indole and azaindole derivative having AMPK-activating activity
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US20170087270A1
(en)
*
|
2014-06-13 |
2017-03-30 |
Avery Dennison Corporation |
Improved pressure-sensitive adhesives used for medical applications
|
EP3423041A4
(de)
|
2016-03-04 |
2019-09-11 |
Charleston Laboratories, Inc. |
Pharmazeutische zusammensetzungen
|